Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Pharmadone AB
AB
In liquidation
Org 5564965423
Manufacture of pharmaceutical preparations · NACE 2120
Est. 1994
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2019
SEK 0
EBITDA margin
—
+96% vs 2018
Equity ratio
83.8%
Financial strength
Net profit 2019
SEK -27K
+90% vs 2018
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
2M
2016
0M
-100%
2017
0M
0%
2017
0M
0%
2018
0M
0%
2019
Key figures
Annual report 2019
Revenue
SEK 0
—
EBITDA
SEK -11K
+96%
Net profit
SEK -27K
+90%
Total assets
SEK 458K
-86%
Equity
SEK 384K
-88%
Employees
0
—
Company information
Legal name
Pharmadone AB
Org number
5564965423
Legal form
Aktiebolag
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
12 oktober 1994
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Company purpose
Föremålet för bolagets verksamhet är beredningslaboratorium och tillverkning av medicin och därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Manufacture of pharmaceutical preparations
Companies in
All Sweden companies
Revenue
SEK millions
0M
1M
2M
3M
3M
3M
2016
2M
2017
0M
2017
0M
2018
0M
2019
EBITDA
SEK millions
0M
1M
1M
2M
2M
2M
2016
0M
2017
0M
2017
0M
2018
0M
2019
Income statement
SEK thousands
Item
2016
2017
2017
2018
2019
Revenue
3 149
2 265
0
−185
0
Staff expenses
—
—
—
—
—
EBITDA
1 639
367
−49
−252
−11
Depreciation & amort.
−112
−125
−14
−18
−13
EBIT
1 527
242
−63
−270
−24
Net financials
—
−14
—
—
−3
Profit before tax
1 528
−2 930
2 934
−270
−27
Tax
−336
645
−646
−0
−0
Net profit
1 192
−2 285
2 288
−270
−27
Balance sheet
SEK thousands
Item
2016
2017
2017
2018
2019
Total assets
5 699
4 674
3 493
3 229
458
Equity
3 380
1 095
3 383
3 112
384
Long-term debt
611
3 399
0
0
0
Short-term debt
1 708
180
111
117
74
Total debt
2 319
3 579
111
117
74
Financial ratios
5-year trend
EBITDA margin
-1100000.0%
This company
15.8%
Market median
-6962125% vs market
2016
2019
Equity ratio
83.8%
This company
38.2%
Market median
+119% vs market
2016
2019
Return on equity
-7.0%
This company
18.4%
Market median
-138% vs market
2016
2019
Net profit margin
-2700000.0%
This company
8.1%
Market median
-33333433% vs market
2016
2019
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2016
2019
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
2016
2019
Annual reports & filings
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2017-05-01 – 2017-12-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2016-05-01 – 2017-04-30
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2015-05-01 – 2016-04-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SK
Snickar Karl Johan Tobieson
Liquidator
Liquidator
2020
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Pharmadone AB also hold positions in
0
other companies.
Person
Role here
Other companies
Snickar Karl Johan Tobieson
Liquidator
0 companies